Correct. Brugger is an experienced pharma executive who played a significant behind-the-scenes role in the Lovenox program. He’s a good speaker, and I’d like to see him play a larger role in investor presentations. Brugger has been with MNTA since 2002, longer than any employee except Ganesh Venkataraman.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”